Section Ph 1104.02 - Informed Consent of Patient or Patient's Authorized Representative(a) Prior to requesting that the patient or the patient's authorized representative sign the collaborative practice agreement, the pharmacist shall ensure that: (1) A copy of the agreement, including each protocol developed pursuant thereto, has been provided with sufficient time for the documents to be reviewed;(2) The patient or the patient's authorized representative has an opportunity to have any questions regarding such documents and their implementation answered to their satisfaction;(3) All benefits and risks accruing under the agreement are fully explained to the patient or the patient's authorized representative;(4) The patient or the patient's authorized representative understands that he or she may decline to participate or withdraw from the agreement at any time; and(5) The patient or the patient's authorized representative is capable of providing informed consent.(b) Informed consent shall be evidenced by a signed informed consent form that complies with the policies and procedures of the institution in which the collaborative practice agreement will be implemented.N.H. Admin. Code § Ph 1104.02
The amended version of this section by New Hampshire Register Volume 38, Number 06, eff. 1/23/2018 is not yet available.